🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Gastrointestinal › Massachusetts › Boston

Qorannoo klinikaalii Kansarii Gastrointestinal Boston, MA keessatti

Qorannoo 15 Kansarii Gastrointestinal f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Brigham and Women's Hospital (BWH), Boston
  • Dana-Farber Cancer Institute (DFCI), Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07222800

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Boston
  • GSK Investigational Site, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07218926

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06445062

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

Namoota walitti qabaa jira
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05375643

Resilience and Equity in Aging, Cancer, and Health (REACH)

Namoota walitti qabaa jira
  • Dana-Farber Cancer Institute, Boston
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT04674267

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Namoota walitti qabaa jiraSadarkaa 2
  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT04899908

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07544589

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital Cancer Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626

BOLSTER: Learning New Skills to Thrive

Namoota walitti qabaa jira
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT06936878

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital,, Boston
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Cam-2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT07020221

Qorannoo Kansarii Gastrointestinal magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.